1652.HK · FUSEN PHARM
Hong Kong · RS rating 62 · As of 2026-10-14
| Price | 0.93 HKD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 62 / 86 / 38 / 72 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 31 / 24 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +33.1% |
| Market cap (USD) | $95.6M |